Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 101,836 | 94,507 | 89,775 | 89,253 | 56,710 |
| Marketable Securities | 15,731 | 15,177 | 13,073 | 13,301 | 14,493 |
| Receivables | 78,738 | 66,390 | 53,837 | 50,544 | 58,598 |
| Inventories | 97,110 | 96,831 | 108,870 | 104,726 | 107,900 |
| TOTAL | $300,164 | $279,682 | $276,541 | $266,821 | $246,724 |
| Non-Current Assets | |||||
| PPE Net | 253,265 | 260,055 | 245,881 | 238,236 | 231,476 |
| Other Non-Current Assets | 92,309 | 91,499 | 91,296 | 95,001 | 94,631 |
| TOTAL | $345,574 | $351,554 | $337,177 | $333,237 | $326,107 |
| Total Assets | $645,738 | $631,236 | $613,718 | $600,058 | $572,831 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,173 | 12,263 | 12,167 | 12,075 | 11,458 |
| Accounts payable and accrued liabilities | 108,545 | 95,504 | 79,292 | 75,385 | 65,438 |
| TOTAL | $127,096 | $112,201 | $96,717 | $93,286 | $83,371 |
| Non-Current Liabilities | |||||
| Long Term Debt | 32,334 | 34,186 | 32,903 | 34,622 | 36,410 |
| Other Non-Current Liabilities | 35,675 | 34,904 | 31,439 | 30,190 | 29,336 |
| TOTAL | $67,682 | $70,312 | $66,039 | $64,335 | $66,087 |
| Total Liabilities | $194,778 | $182,513 | $162,756 | $157,621 | $149,458 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,635 | 47,433 | 47,504 | 47,486 | 46,198 |
| Common Shares | 6 | 5 | 5 | 5 | 5 |
| Retained earnings | 122,814 | 117,773 | 124,046 | 120,127 | 120,319 |
| Other shareholders' equity | 40,214 | 42,884 | 40,827 | 39,464 | 39,905 |
| TOTAL | $450,960 | $448,723 | $450,962 | $442,437 | $423,373 |
| Total Liabilities And Equity | $645,738 | $631,236 | $613,718 | $600,058 | $572,831 |